Clinical Trials on FGFR3 Protein Overexpression in Singapore
Total 51 results
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Singapore Institute of TechnologyAMILI Pte. Ltd.Active, not recruitingGastrointestinal Microbiome | Protein DigestionSingapore
-
Relay Therapeutics, Inc.Active, not recruitingCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Amplification | FGFR2 Gene Fusion/Rearrangement | FGFR2 Gene Translocation | FGFR2 Gene Activation | Other Solid Tumors, AdultUnited States, France, Italy, United Kingdom, Korea, Republic of, Spain, Taiwan, Sweden, Germany, Netherlands, Singapore, Australia, Hong Kong
-
BayerTerminatedMedical OncologyUnited States, Korea, Republic of, Singapore
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Clinical Nutrition Research Centre, SingaporePrince September Pte. Ltd.RecruitingCardiovascular Diseases | Diabetes Mellitus | Protein Metabolism DisorderSingapore
-
Singapore General HospitalCompleted
-
National University Hospital, SingaporeNational University of SingaporeRecruiting
-
National University Hospital, SingaporeUnknownMultiple MyelomaSingapore
-
Singapore General HospitalJanssen, LP; International Myeloma FoundationActive, not recruitingMultiple Myeloma | MyelomaSingapore
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeCelgeneUnknownMultiple Myeloma | Relapse After Use of Lenalidomide and BortezomibSingapore
-
Changi General HospitalCompletedArrhythmias, Cardiac | Seizures | Hypocalcemia | Hypokalemia | Hypomagnesemia | Proton Pump Inhibitor Adverse ReactionSingapore
-
Singapore General HospitalNational Medical Research Council (NMRC), SingaporeCompletedAcute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Non Hodgkin's Lymphoma | Hodgkin's DiseaseSingapore
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaHong Kong, Korea, Republic of, Singapore
-
Gleneagles HospitalSamsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaboratorsCompletedMultiple MyelomaKorea, Republic of, Singapore, India
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...UnknownRelapsed and/or Refractory Multiple MyelomaSingapore, Hong Kong, Korea, Republic of, Taiwan
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States, Singapore
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
NestléCompletedCow's Milk Protein AllergySingapore, Italy, United Kingdom, Belgium, Poland, Spain, Hungary
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Germany, Spain, Singapore
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of
-
Novartis PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States, Singapore, Israel, Australia
-
Christian Medical College, Vellore, IndiaUnknownHemophiliaIndia, Argentina, Brazil, Egypt, Iran, Islamic Republic of, Singapore, South Africa, Thailand, Venezuela
-
PfizerCompletedHemophilia BCanada, Singapore, Turkey, Croatia, Korea, Republic of, Mexico, Poland, Bulgaria, Malaysia
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedChronic Lymphocytic Leukaemia (CLL) | Multiple Myeloma (MM) | B-Cell Non-Hodgkin Lymphoma (NHL)France, Australia, Germany, Korea, Republic of, United Kingdom, Hungary, Poland, Singapore
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphoma | Multiple Myeloma | AmyloidosisUnited States, China, Belgium, Canada, Poland, Spain, Korea, Republic of, Greece, Singapore, Japan, Sweden
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, France, Spain, Israel, India, Romania, Korea, Republic of, Singapore, Russian Federation, Poland
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Greece, Korea, Republic of, Singapore
-
Novartis PharmaceuticalsRecruitingMultiple MyelomaGermany, France, Canada, Spain, Brazil, Israel, Japan, United Kingdom, Italy, Singapore, Greece, United States, Saudi Arabia, Australia
-
BayerCompletedHemophilia AKorea, Republic of, Taiwan, Turkey, Singapore, United States, Netherlands, Austria, Denmark, United Kingdom, Belgium, Italy, France, Japan, Germany, Israel, Poland, Canada, Norway, Romania, Colombia
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.Active, not recruitingHemophilia ASpain, United States, Denmark, Italy, Taiwan, Malaysia, Belgium, Thailand, Turkey, Austria, Bulgaria, Canada, Finland, France, Germany, Hong Kong, Hungary, Korea, Republic of, Netherlands, Norway, Singapore, Ukraine, United Kingdom
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia ASpain, United States, Australia, Singapore, Taiwan, Hong Kong, Malaysia, Bulgaria, United Kingdom, Switzerland, Ukraine, Turkey, Italy, Norway, France, Austria, Romania, Sweden, Poland, Germany, Hungary, Israel
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Spain, Australia, Brazil, United Kingdom, Poland, Taiwan, Singapore, France, Italy
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
Janssen Research & Development, LLCCompletedMultiple MyelomaAustralia, France, Poland, United Kingdom, United States, Spain, Israel, Portugal, South Africa, Canada, Netherlands, Belgium, Singapore, Russian Federation, Czech Republic, Argentina, Austria
-
BayerCompletedHemophilia A, Hemophilia BItaly, China, New Zealand, Russian Federation, Taiwan, Singapore, Bulgaria, United States, Denmark, Germany, Hungary, South Africa, United Kingdom, Romania, Colombia, Mexico, Turkey, France, India, Japan, Australia, Netherlands, Poland and more
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
AmgenCompletedMultiple MyelomaKorea, Republic of, China, Spain, Taiwan, United States, Netherlands, Australia, Singapore, New Zealand, United Kingdom, Israel, France, Japan, Italy, Czechia, Belgium, Argentina, Austria, Bulgaria, Canada, Germany, Greece, Hungary, M... and more
-
AbbVieRoche-GenentechActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, China, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Russian Federation, Singapore, Spain, Sweden, Turkey, Ukraine, United Kingdom
-
Novartis PharmaceuticalsCompletedMultiple MyelomaChina, United States, Italy, Taiwan, Egypt, Japan, Turkey, Germany, Netherlands, Canada, Australia, Austria, Israel, Sweden, United Kingdom, Korea, Republic of, Spain, Hong Kong, Thailand, France, Belgium, Norway, South Africa, Brazil, ... and more
-
TakedaCompletedMultiple MyelomaFrance, Spain, United States, Taiwan, Korea, Republic of, Israel, Australia, Czechia, Hungary, Canada, Japan, Portugal, Singapore, United Kingdom, Italy, Sweden, Poland, Germany, China, Denmark, Greece, Thailand, Serbia, Turkey, Colombia, Russian Federation and more
-
AmgenCompletedMultiple MyelomaKorea, Republic of, Spain, Taiwan, Canada, Australia, Israel, Italy, United States, Singapore, New Zealand, Japan, Thailand, Brazil, United Kingdom, Hungary, Czechia, Romania, Slovakia, France, Germany, Russian Federation, Bulgaria, Belgiu... and more
-
Bristol-Myers SquibbRecruitingMultiple MyelomaCanada, Taiwan, United States, Australia, Denmark, China, Korea, Republic of, Israel, Spain, France, Germany, Czechia, Austria, Japan, Sweden, United Kingdom, Greece, Italy, Finland, Argentina, Belgium, Brazil, Colombia, Hong Kong, India, Mexic... and more
-
TakedaActive, not recruitingMultiple Myeloma | Autologous Stem Cell TransplantUnited States, Spain, Australia, Czechia, Hungary, Taiwan, Italy, Denmark, Portugal, Singapore, Israel, Canada, France, Belgium, United Kingdom, Germany, Japan, Austria, Netherlands, Korea, Republic of, Poland, Greece, Colombia, Sweden, South Africa and more
-
AmgenDaiichi Sankyo, Inc.CompletedCancer | Multiple Myeloma | Bone Metastases | Hematologic Malignancies | Oncology | Multiple Myeloma Bone LesionsUnited States, Germany, Italy, Spain, Canada, France, Czechia, Hungary, Korea, Republic of, Russian Federation, United Kingdom, Taiwan, Australia, Hong Kong, New Zealand, Austria, Slovakia, Portugal, Greece, Bulgaria, Poland, Ukraine and more